Literature DB >> 15894884

Preventing pregnancy-induced hypertension: are there regional differences for this global problem?

Patricio López-Jaramillo1, Ronald G García, Marcos López.   

Abstract

Developing countries have had persistently higher rates of maternal and child mortality due to pre-eclampsia in comparison with developed countries. Moreover, evidence from studies of interventions to prevent pre-eclampsia have given contradictory results. In this review, we discuss the underlying causes of pre-eclampsia, and the results of clinical trials performed to prevent this disease, that support the proposal that the causes and strategies to prevent pre-eclampsia are different in developed and developing countries. We also suggest that the establishment of an adequate prenatal care is the only effective way to reduce the incidence of pre-eclampsia in populations from developing countries, especially in women at high risk of pregnancy-induced hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 15894884     DOI: 10.1097/01.hjh.0000170371.49010.4a

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  12 in total

Review 1.  Comparative risks and predictors of preeclamptic pregnancy in the Eastern, Western and developing world.

Authors:  Ning Zhang; Jing Tan; HaiFeng Yang; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2020-09-25       Impact factor: 5.858

Review 2.  Pregnancy-Related Hypertensive Disorders and Immigrant Status: A Systematic Review and Meta-analysis of Epidemiological Studies.

Authors:  Mulubrhan F Mogos; Abraham A Salinas-Miranda; Jason L Salemi; Imelda M Medina; Hamisu M Salihu
Journal:  J Immigr Minor Health       Date:  2017-12

Review 3.  Impact of direct soil exposures from airborne dust and geophagy on human health.

Authors:  David Sing; Charles F Sing
Journal:  Int J Environ Res Public Health       Date:  2010-03-19       Impact factor: 3.390

4.  Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia.

Authors:  Frauke M von Versen-Hoeynck; Carl A Hubel; Marcia J Gallaher; Hilary S Gammill; Robert W Powers
Journal:  Am J Hypertens       Date:  2009-03-12       Impact factor: 2.689

Review 5.  Predicting later-life outcomes of early-life exposures.

Authors:  Kim Boekelheide; Bruce Blumberg; Robert E Chapin; Ila Cote; Joseph H Graziano; Amanda Janesick; Robert Lane; Karen Lillycrop; Leslie Myatt; J Christopher States; Kristina A Thayer; Michael P Waalkes; John M Rogers
Journal:  Environ Health Perspect       Date:  2012-06-06       Impact factor: 9.031

6.  Clinical trial to assess the effect of physical exercise on endothelial function and insulin resistance in pregnant women.

Authors:  Robinson Ramírez-Vélez; Ana C Aguilar; Mildrey Mosquera; Ronald G Garcia; Laura M Reyes; Patricio López-Jaramillo
Journal:  Trials       Date:  2009-11-17       Impact factor: 2.279

7.  Risk factors for preeclampsia in women from Colombia: a case-control study.

Authors:  Laura M Reyes; Ronald G García; Silvia L Ruiz; Paul A Camacho; Maria B Ospina; Gustavo Aroca; Jose L Accini; Patricio López-Jaramillo
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

Review 8.  The role of soils in provision of genetic, medicinal and biochemical resources.

Authors:  Sören Thiele-Bruhn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-08-04       Impact factor: 6.671

9.  Fish Oil Supplementation does not Reduce Risks of Gestational Diabetes Mellitus, Pregnancy-Induced Hypertension, or Pre-Eclampsia: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Bing Chen; Xinran Ji; Lei Zhang; Zhaohui Hou; Chundong Li; Ying Tong
Journal:  Med Sci Monit       Date:  2015-08-09

10.  Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis.

Authors:  Ver Luanni Bilano; Erika Ota; Togoobaatar Ganchimeg; Rintaro Mori; João Paulo Souza
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.